Astrazeneca PLC ORD SHS $0.25
Astrazeneca PLC ORD SHS $0.25/ GB0009895292 /
AZN
|
10/2/2023 5:38:11 PM
|
Chg.
-152.0
|
Volume |
Bid6:30:00 PM |
Ask6:30:00 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
10,950.0GBX
|
-1.37%
|
3.82 mill.
Turnover(GBP): 114.57 mill. |
10,200.0Bid Size: 500 |
11,110.0Ask Size: 100 |
170.46 bill.GBP |
- |
- |
Fundamentals
| |
FY 2022 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
2.12 USD |
2,550.00% |
| EPS Diluted: |
- USD |
2,537.50% |
| Revenues per Share: |
28.61 USD |
8.44% |
| Book Value per Share: |
23.89 USD |
-13.76% |
| Cash Flow per Share: |
6.33 USD |
50.47% |
| Dividend per Share: |
2.90 USD |
3.57% |
| Total |
in mill. |
|
| Revenues: |
44,351.00 USD |
18.53% |
| Net Income: |
3,228.00 USD |
2,782.14% |
| Operating Cash Flow: |
9,808.00 USD |
- |
| Cash and Cash Equivalents: |
6,166.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
62.74 |
63.87 |
| P/S Ratio: |
4.65 |
4.73 |
| P/BV ratio: |
5.57 |
5.67 |
| P/CF Ratio: |
21.02 |
21.40 |
| PEG: |
0.02 |
0.03 |
| Earnings Yield: |
1.59% |
1.57% |
| Dividend Yield: |
2.18% |
2.14% |
| Market Capitalization |
|
| Market Capitalization: |
170.46 bill. GBP |
173.6 bill. GBP |
| Free Float Market Cap.: |
125.46 bill. GBP |
- GBP |
| Market Cap. / Employee: |
2.04 mill. GBP |
2.08 mill. GBP |
| Shares Outstanding: |
1.55 bill. |
|
Profitability
| Gross Profit Margin: |
72.06% |
| EBIT Margin: |
8.47% |
| Net Profit Margin: |
7.28% |
| Return on Equity: |
8.72% |
| Return on Assets: |
3.35% |
Financial Strength
| Liquidity I / Cash Ratio: |
23.45% |
| Liquidity II / Quick Ratio: |
51.10% |
| Liquidity III / Current Ratio: |
85.93% |
| Debt / Equity Ratio: |
160.50% |
| Dynam. Debt / Equity Ratio: |
606.10% |
Efficiency
| Employees: |
83,500 |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
531,149.70 USD |
| Net Income / Employee: |
38,658.68 USD |
| Total Assets / Employee: |
1,155,485.03 USD |
| * Fiscal Year End: |
12/31/2022 |
| Accounting Standard: |
IFRS |